Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III confirmatory trial of betaine anhydrous powder for hereditary homocystinuria
CTR20253844Phase 3Active
- Sponsor
- Yichun Wujiashen Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of betaine in homocystinuria (HCU), sponsored by Yichun Wujiashen Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
betaine
03
Conditions
homocystinuria (HCU)
Beyond the preview
Go deeper on CTR20253844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253844.